<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Neurol</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Neurology</journal-title></journal-title-group><issn pub-type="ppub">2168-6149</issn><issn pub-type="epub">2168-6157</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10644251</article-id><article-id pub-id-type="pmcid-ver">PMC10644251.1</article-id><article-id pub-id-type="pmcaid">10644251</article-id><article-id pub-id-type="pmcaiid">10644251</article-id><article-id pub-id-type="pmid">37955917</article-id><article-id pub-id-type="doi">10.1001/jamaneurol.2023.4207</article-id><article-id pub-id-type="publisher-id">noi230082</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="featured" specific-use="electronic"><subject>Featured</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Risk of Suicidal Ideation and Behavior in Individuals With Parkinson Disease</article-title><subtitle>A Systematic Review and Meta-Analysis</subtitle><alt-title alt-title-type="headline">Risk of Suicidal Ideation and Behavior in Individuals With Parkinson Disease</alt-title><alt-title alt-title-type="running-head">Risk of Suicidal Ideation and Behavior in Individuals With Parkinson Disease</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mai</surname><given-names initials="AS">Aaron Shengting</given-names></name><degrees>MS</degrees><xref rid="noi230082aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chao</surname><given-names initials="Y">Yinxia</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="noi230082aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xiao</surname><given-names initials="B">Bin</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="noi230082aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="Z">Zhidong</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="noi230082aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yong</surname><given-names initials="JH">Jung Hahn</given-names></name><degrees>MS</degrees><xref rid="noi230082aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="ARYB">Ainsley Ryan Yan Bin</given-names></name><degrees>MBBS</degrees><xref rid="noi230082aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Tan</surname><given-names initials="EK">Eng-King</given-names></name><degrees>MD</degrees><xref rid="noi230082aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="noi230082aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="noi230082aff1"><label>1</label>Yong Loo Lin School of Medicine, National University of Singapore, Singapore</aff><aff id="noi230082aff2"><label>2</label>Department of Neurology, Singapore General Hospital Campus, National Neuroscience Institute, Singapore</aff><aff id="noi230082aff3"><label>3</label>Neuroscience and Behavioral Disorders, Duke-NUS Medical School, Singapore</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> September 8, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> November 13, 2023. doi:<uri content-type="doi">10.1001/jamaneurol.2023.4207</uri></p><corresp id="noi230082cor1"><bold>Corresponding Author</bold><bold>:</bold> Eng-King Tan, MD, Department of Neurology, Singapore General Hospital Campus, National Neuroscience Institute, Neuroscience and Behavioral Disorders, Duke-NUS Medical School, 8 College Road, Singapore 169857 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gnrtek@sgh.com.sg">gnrtek@sgh.com.sg</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Mai and Tan had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Mai, Chao, Zhou, Lee, Tan.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> All authors.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Mai, Chao, Yong, Tan.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content:</italic> Mai, Chao, Xiao, Zhou, Lee, Tan.</p><p><italic toggle="yes">Statistical analysis:</italic> Mai, Chao, Xiao, Zhou, Yong, Tan.</p><p><italic toggle="yes">Obtained funding:</italic> Tan.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Mai, Chao, Xiao, Tan.</p><p><italic toggle="yes">Supervision:</italic> Lee, Tan.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Tan reported honoraria from Eisai and Elsevier outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> Dr Tan is supported by the National Medical Research Council (STaR and OF-LCG-000207, SPARKS II Programme).</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-NOI230082-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-11-13T10:00"><day>13</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2024</year></pub-date><volume>81</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">449086</issue-id><fpage>10</fpage><lpage>18</lpage><history><date date-type="received"><day>12</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>8</day><month>9</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>13</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>13</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-13 00:25:30.853"><day>13</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamaneurol-e234207.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamaneurol-e234207.pdf">jamaneurol-e234207.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archneur/fullarticle/10.1001/jamaneurol.2023.4207"/><abstract abstract-type="teaser" specific-use="electronic"><p>This study addresses inconsistent results from studies of suicidal ideation and behavior in patients with Parkinson PD.</p></abstract><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-noi230082-1"><title>Question</title><p>What is the prevalence and risk of suicidal ideation and behavior in patients with Parkinson disease (PD)?</p></sec><sec id="ab-noi230082-2"><title>Findings</title><p>This meta-analysis of 28 studies found a high prevalence of suicidal ideation and behavior in patients with PD. Compared with controls, patients with PD experienced 2 times the risk of engaging in suicidal behavior.</p></sec><sec id="ab-noi230082-3"><title>Meaning</title><p>Patients with PD may be at elevated risks of both suicidal ideation and behavior, and physicians ought to maintain a high index of suspicion for early detection and appropriate management.</p></sec></abstract><abstract><sec id="ab-noi230082-4"><title>Importance</title><p>Suicide risk may be increased in patients with Parkinson disease (PD), a common neurodegenerative condition. Mood disorders, especially depression, are prevalent in patients with PD who report suicidality.</p></sec><sec id="ab-noi230082-5"><title>Objective</title><p>To address inconsistent results from studies of suicidal ideation and behavior in patients with PD.</p></sec><sec id="ab-noi230082-6"><title>Data Sources</title><p>The study team searched MEDLINE and Embase from inception to June 14, 2023, and further screened the bibliographies of relevant studies to ensure a comprehensive search.</p></sec><sec id="ab-noi230082-7"><title>Study Selection</title><p>Original studies, published in English, discussing either suicidal ideation, behavior, or both in adults with PD were included. Accepted study designs included cross-sectional, case-control, and cohort studies. Studies that only included patients with PD after deep brain stimulation were excluded.</p></sec><sec id="ab-noi230082-8"><title>Data Extraction and Synthesis</title><p>This meta-analysis was conducted in line with the PRISMA guidelines. Two authors reviewed each study and extracted the data independently, with discrepancies referred to a third independent author.</p></sec><sec id="ab-noi230082-9"><title>Main Outcomes and Measures</title><p>Outcomes included the prevalence of suicidal ideation and behavior, measured as proportions, and the risk of suicidal behavior in patients with PD relative to controls, measured in both odds ratio (OR) and hazards ratio (HR).</p></sec><sec id="ab-noi230082-10"><title>Results</title><p>A total of 28 studies comprising 505&#8201;950 PD patients were included in the final analysis. The prevalence of suicidal ideation was evaluated in 14 studies (22.2%; 95% CI, 14.6-32.3) and suicidal behavior in 21 studies (1.25%; 95% CI, 0.64-2.41). Excluding 4 outliers, prevalence of suicidal behavior was significantly higher in prospective studies (1.75%; 95% CI, 1.03-2.95) than retrospective studies (0.50%; 95% CI, 0.24-1.01). Excluding 1 outlier, OR of suicidal behavior was pooled across 10 studies and significant (OR, 2.15; 95% CI, 1.22-3.78; <italic toggle="yes">P</italic>&#8201;=&#8201;.01). HR of suicidal behavior was assessed in 9 studies (HR, 1.73; 95% CI, 1.40-2.14; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001).</p></sec><sec id="ab-noi230082-11"><title>Conclusions and Relevance</title><p>This meta-analysis involving more than 500&#8201;000 patients with PD found 22.2% and 1.25% of patients with PD to have suicidal ideation and behavior, respectively. Patients with PD had 2 times the risk of suicidal behavior than controls. Early recognition and management of suicidality in PD can help reduce mortality.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>